TGFB1 and epilepsy: A combination of losartan (an angiotensin II type 1 receptor antagonist that blocks brain TGF-β signaling) and clinically available NMDA receptor antagonists such as memantine may be advantageous in preventing BBB disruption in a wide variety of brain diseases, including epilepsy, stroke, Alzheimer’s disease, and traumatic brain injury [48].